Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Glenmark
Welcome,
Profile
Billing
Logout
26 Products
47 Diseases
26 Products
407 Trials
3550 News
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
16
32
48
64
80
96
112
128
144
160
Ameile
(aumolertinib) / Jiangsu Hansoh Pharma
Enweida
(envafolimab) / 3DMed, Ascletis
Avida
(trastuzumab rezetecan) / Jiangsu Hengrui Pharma
Cibinqo
(abrocitinib) / Pfizer
Akynzeo oral
(netupitant/palonesteron FDC) / Helsinn
Winlevi
(clascoterone cream 1%) / Cosmo Pharma
Ryaltris
(olopatadine/mometasone) / Glenmark
vatelizumab
(GBR 500) / Glenmark
ISC 17536
/ Glenmark
oglemilast
(GRC 3886) / Glenmark, AbbVie
telazorlimab
(ISB 830) / BioCryst Pharmaceuticals
ABBV-2001
/ AbbVie
ISB 1302
/ Glenmark
ISB 1442
/ Glenmark
Revamilast
(GRC-4039) / Glenmark
zaloglanstat
(ISC 27864) / Glenmark
GBR 900
/ Glenmark
GRC 15300
/ Glenmark
GRC 54276
/ Glenmark
GRC 6211
/ Eli Lilly
ISB 1342
/ Glenmark
melogliptin
(GRC 8200) / Glenmark
tedalinab
(GRC-10693) / Glenmark
tiotropium bromide solution
(GSP-304) / Glenmark
